Crossmark

Impact of Retroperitoneal Lymphadenopathy (RPLN) on the Outcomes of Locally Advanced Gall Bladder Cancer (GBC) Following Chemotherapy (CT) or Chemotherapy Followed by Consolidation Chemoradiotherapy (CTRT)

Crossref DOI link: https://doi.org/10.1007/s12029-024-01124-5

Published Online: 2024-10-19

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agrawal, Sushma

Naik, Nagendra

Priyanka, Parul
License Information

Text and Data Mining valid from 2024-10-19

Version of Record valid from 2024-10-19
More Information

Article History

Accepted: 22 September 2024

First Online: 19 October 2024

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of SGPGI, Lucknow, PGI/BE/2019.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below